Patent Assignment
Reel/Frame 048431/0035
Assignment of Assignor's Interest
Recorded: 2019-02-25
Pages: 5
Assignee
WALLKILL BIOPHARMA, INC.
P.O. BOX 9916, RANCHO SANTA FE, CALIFORNIA, 92067
Covered Properties
(12)
Treating Diabetes with Genetically Modified Beta Cells
Application:
16/146,980 →
Publication:
US 2019/0100730
Treating Diabetes with Genetically Modified Beta Cells
Application:
16/146,965 →
Publication:
US 2019/0100729
Treating Diabetes with Genetically Modified Beta-Cells
Application:
62/734,910 →
Treating Diabetes with Genetically Modified Beta-Cells
Application:
62/719,975 →
Treating Diabetes with Genetically Modified Beta-Cells
Application:
62/717,587 →
Treating Diabetes with Genetically Altered Beta-Cells
Application:
62/696,603 →
Treating Diabetes with Genetically Altered Beta-Cells
Application:
62/694,634 →
Treating Diabetes with Genetically Altered Beta-Cells
Application:
62/662,651 →
Treating Diabetes with Genetically Altered Beta-Cells
Application:
62/637,913 →
Treating Diabetes with Genetically Altered Beta-Cells
Application:
62/568,117 →
Treating Diabetes with Genetically Altered Beta-Cells
Application:
62/567,604 →
Treating Diabetes with Genetically Modified Beta Cells
PCT:
PCT/US2018/053599 ↗
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 5, 2017
From: SWISS, GERALD F.
To: WALLKILL BIOPHARMA, INC.
Reel/Frame 044303/0639 →
Assignment of Assignor's Interest
Dec 5, 2017
From: SWISS, GERALD F.
To: WALLKILL BIOPHARMA, INC.
Reel/Frame 044303/0790 →
Change of Name
Jul 30, 2020
From: WALLKILL BIOPHARMA INC.
To: SDF BIOPHARMA INC.
Reel/Frame 053365/0714 →